Publications by authors named "Stephen Gately"

Claim this Profile
H
Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.
Stephen Gately

Cancer Treat Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of improved lysomotropic autophagy inhibitors.
Tong Wang, Megan L Goodall, Paul Gonzales, Mario Sepulveda, Katie R Martin, Stephen Gately

J Med Chem· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib.
Megan L Goodall, Tong Wang, Katie R Martin, Matthew G Kortus, Audra L Kauffman, Stephen Gately

Autophagy· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel HDAC inhibitors through cell based screening and their evaluation as potential anticancer agents.
Tong Wang, Mario Sepulveda, Paul Gonzales, Stephen Gately

Bioorg Med Chem Lett· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression.
Todd D Levine, Robert Bowser, Nicole C Hank, Stephen Gately, Dietrich Stephan

Neurol Res Int· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer.
Tobias Hahn, Deborah J Bradley-Dunlop, Laurence H Hurley, Daniel Von-Hoff, Stephen Gately

BMC Cancer· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites.
Danielle Frost, Bessie Meechoovet, Tong Wang, Stephen Gately, Marco Giorgetti

PLoS One· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cyclooxygenase-2 for cancer prevention and treatment.
Stephen T Gately

Prog Drug Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy.
Stephen Gately, William W Li

Semin Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis.
Stephen Gately, Robert Kerbel

Prog Exp Tumor Res· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor production of angiostatin is enhanced after exposure to TNF-alpha.
Helena J Mauceri, Saraswathy Seetharam, Michael A Beckett, John Y Lee, Vinay K Gupta, Stephen Gately

Int J Cancer· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis